The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 08, 2019
Filed:
Apr. 10, 2014
Applicant:
Ceva Sante Animale, Libourne, FR;
Inventor:
Takanori Sato, Kanagawa, JP;
Assignee:
CEVA SANTE ANIMALE, Libourne, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C07K 14/005 (2006.01); A61K 39/12 (2006.01); A61K 39/385 (2006.01); C12N 7/00 (2006.01); A61K 35/76 (2015.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61K 39/385 (2013.01); C12N 7/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/552 (2013.01); A61K 2039/6075 (2013.01); C07K 2319/02 (2013.01); C12N 2710/24021 (2013.01); C12N 2710/24043 (2013.01); C12N 2710/24122 (2013.01); C12N 2750/10022 (2013.01); C12N 2750/10034 (2013.01); C12N 2750/10071 (2013.01);
Abstract
The present invention relates to novel immunogenic polypeptides and their use in vaccine compositions. The invention also relates to nucleic acids, vectors and cells which express the polypeptides and the uses thereof. The polypeptides of the invention more specifically comprise an immunogenic domain and a cell membrane addressing domain which is derived from a B5R gene. The invention is particularly suited to produce vaccines for non-human animals, particularly for vaccinating swine against PCV2 infection.